Literature DB >> 26318663

AMPK-independent autophagy promotes radioresistance of human tumor cells under clinical relevant hypoxia in vitro.

Hassan Chaachouay1, Birgit Fehrenbacher2, Mahmoud Toulany3, Martin Schaller2, Gabriele Multhoff4, H Peter Rodemann5.   

Abstract

BACKGROUND AND
PURPOSE: Blocking of the autophagy-signaling has the potential to improve cancer therapy. In the present study, the role of autophagy for radioresistance of human tumor cells was tested under clinically relevant hypoxia (1% O2).
MATERIALS AND METHODS: Non-small cell lung cancer cell lines A549 and H460, head and neck squamous cell carcinoma FaDu, colon carcinoma cell line HCT116 and mouse-embryo-fibroblasts were analyzed under normoxic (21% O2) and hypoxic (0.01% and 1% O2) conditions with respect to clonogenic cell survival and hypoxia-induced autophagy. Immunofluorescence and electron microscopy were used to monitor the autophagy process and Western blotting of LC3, AMPK, and BNIP3 was applied to analyze autophagy signaling.
RESULTS: Clinically relevant hypoxia stimulated autophagy in tumor cells as indicated by enhanced LC3-I to LC3-II conversion. Furthermore, hypoxia stimulated autophagy was approved by Immunofluorescence staining and electron-microscopy analysis of autophagosome vacuoles. Preconditioning of tumor cells to moderate-hypoxia increased their radioresistance that was significantly reversed following pretreatment with autophagy inhibitor, chloroquine. Using siRNA against AMPK as well as AMPK deficient cells, autophagy stimulation by 1% O2 was shown to be AMPK-independent. However, a correlation between the expression of BNIP3 and autophagy-stimulation was observed under this condition.
CONCLUSION: Under clinically relevant hypoxia (1% O2) the stimulation of autophagy mediates resistance of hypoxic tumor cells to ionizing radiation, which is independent of AMPK signaling.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Autophagy; Clinical relevant hypoxia; Ionizing radiation; Solid tumor cells

Mesh:

Substances:

Year:  2015        PMID: 26318663     DOI: 10.1016/j.radonc.2015.08.012

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  11 in total

1.  Lys05 - A Promising Autophagy Inhibitor in the Radiosensitization Battle: Phosphoproteomic Perspective.

Authors:  Martin Ondrej; Lucie Cechakova; Ivo Fabrik; Jana Klimentova; Ales Tichy
Journal:  Cancer Genomics Proteomics       Date:  2020 Jul-Aug       Impact factor: 4.069

Review 2.  Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer.

Authors:  Giulia Petroni; Lewis C Cantley; Laura Santambrogio; Silvia C Formenti; Lorenzo Galluzzi
Journal:  Nat Rev Clin Oncol       Date:  2021-11-24       Impact factor: 66.675

3.  Upregulation of nuclear division cycle 80 contributes to therapeutic resistance via the promotion of autophagy-related protein-7-dependent autophagy in lung cancer.

Authors:  Xi Chen; Qingchun He; Shuangshuang Zeng; Zhijie Xu
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

Review 4.  The 3PAs: An Update on the Association of Pheochromocytomas, Paragangliomas, and Pituitary Tumors.

Authors:  Paraskevi Xekouki; Ana Brennand; Ben Whitelaw; Karel Pacak; Constantine A Stratakis
Journal:  Horm Metab Res       Date:  2018-10-01       Impact factor: 2.936

Review 5.  Autophagy is not uniformly cytoprotective: a personalized medicine approach for autophagy inhibition as a therapeutic strategy in non-small cell lung cancer.

Authors:  Tareq Saleh; Laurie Cuttino; David A Gewirtz
Journal:  Biochim Biophys Acta       Date:  2016-06-15

Review 6.  Carney Triad, Carney-Stratakis Syndrome, 3PAS and Other Tumors Due to SDH Deficiency.

Authors:  Georgia Pitsava; Nikolaos Settas; Fabio R Faucz; Constantine A Stratakis
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-03       Impact factor: 5.555

7.  AKT2 suppresses pro-survival autophagy triggered by DNA double-strand breaks in colorectal cancer cells.

Authors:  Nina Seiwert; Carina Neitzel; Svenja Stroh; Teresa Frisan; Marc Audebert; Mahmoud Toulany; Bernd Kaina; Jörg Fahrer
Journal:  Cell Death Dis       Date:  2017-08-24       Impact factor: 8.469

8.  Transportable system enabling multiple irradiation studies under simultaneous hypoxia in vitro.

Authors:  Olli Metsälä; Joose Kreutzer; Heidi Högel; Petra Miikkulainen; Pasi Kallio; Panu M Jaakkola
Journal:  Radiat Oncol       Date:  2018-11-13       Impact factor: 3.481

9.  Akt1 Stimulates Homologous Recombination Repair of DNA Double-Strand Breaks in a Rad51-Dependent Manner.

Authors:  Katharina Mueck; Simone Rebholz; Mozhgan Dehghan Harati; H Peter Rodemann; Mahmoud Toulany
Journal:  Int J Mol Sci       Date:  2017-11-20       Impact factor: 5.923

Review 10.  Activation of AMPK under Hypoxia: Many Roads Leading to Rome.

Authors:  Franziska Dengler
Journal:  Int J Mol Sci       Date:  2020-03-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.